potential, stem cells are already a valuable tool for studying Huntington's disease in the laboratory. Clinical trials In 2020, there were 197 clinical trials related to varied therapies and biomarkers for Huntington's disease listed as either underway, recruiting or newly completed. Compounds trialled, that have failed to prevent or slow the progression of Huntington's disease include remacemide, coenzyme Q10, riluzole, creatine, minocycline, ethyl-EPA, phenylbutyrate and dimebon. See also References External links HOPES project – Stanford University's HD information project HDBuzz – HD research news written by scientists in plain language HD Drug Works – news about current treatments and planned trials Autosomal dominant disorders Disorders causing seizures Extrapyramidal and movement disorders Genetic diseases and disorders Wikipedia medicine articles ready to translate Wikipedia neurology articles ready to translate Systemic atrophies primarily affecting the central nervous system Trinucleotide repeat disorders Diseases named for discoverer